NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

Q: What does CUSIP 44975P103 represent in this 13F holders report?

CUSIP 44975P103 is the security identifier for NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) used to aggregate holder disclosures.

Q: How many institutions held NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in Q4 2022?

63 institutional investors reported NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) for Q4 2022. Use the holders table for investor-level position and value details.

CUSIP: 44975P103

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding: 265,214,861
Total 13F shares: 24,863,205
Share change: -5,860,379
Total reported value: $103,919,915
Put/Call ratio: 13%
Price per share: $4.18
Number of holders: 63
Value change: -$23,835,362
Number of buys: 31
Number of sells: 34

Quarterly Holders Quick Answers

What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 44975P103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
HHLR ADVISORS, LTD.	13F	Company	2.7%	7,182,850	$28,803,000	—	30 Sep 2022	13F
NOMURA HOLDINGS INC	13F	Company	0.99%	2,613,207	$10,479,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	0.86%	2,271,671	$9,110,000	—	30 Sep 2022	13F
Cederberg Capital Ltd	13F	Company	0.84%	2,215,385	$8,884,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	0.76%	2,013,202	$8,073,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0.71%	1,892,641	$7,589,000	—	30 Sep 2022	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.67%	1,768,000	$7,090,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.43%	1,138,338	$4,565,000	—	30 Sep 2022	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.35%	927,400	$3,719,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.33%	866,739	$3,476,000	—	30 Sep 2022	13F
Artal Group S.A.	13F	Company	0.32%	850,000	$3,409,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.24%	627,707	$2,517,000	—	30 Sep 2022	13F
Temasek Holdings (Private) Ltd	13F	Company	0.21%	566,650	$2,272,267	—	30 Sep 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.19%	507,239	$2,024,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	0.18%	481,638	$1,931,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.18%	473,579	$1,899,000	—	30 Sep 2022	13F
Assenagon Asset Management S.A.	13F	Company	0.17%	462,867	$1,856,000	—	30 Sep 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.17%	458,706	$1,839,411	—	30 Sep 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.17%	439,809	$1,764,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.09%	231,200	$927,000	—	30 Sep 2022	13F
EDBI Pte Ltd	13F	Company	0.08%	222,136	$891,000	—	30 Sep 2022	13F
Bridgewater Associates, LP	13F	Company	0.08%	213,406	$856,000	—	30 Sep 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.06%	166,548	$668,000	—	30 Sep 2022	13F
Tekla Capital Management LLC	13F	Company	0.06%	162,580	$652,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	161,100	$646,000	—	30 Sep 2022	13F
Alberta Investment Management Corp	13F	Company	0.05%	142,623	$572,000	—	30 Sep 2022	13F
Handelsbanken Fonder AB	13F	Company	0.05%	120,502	$483,000	—	30 Sep 2022	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	113,278	$454,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	0.04%	110,815	$444,000	—	30 Sep 2022	13F
Trexquant Investment LP	13F	Company	0.04%	105,288	$422,000	—	30 Sep 2022	13F
E Fund Management Co., Ltd.	13F	Company	0.04%	102,157	$410,000	—	30 Sep 2022	13F
MASO CAPITAL PARTNERS Ltd	13F	Company	0.04%	100,000	$401,000	—	30 Sep 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	0.03%	92,216	$370,000	—	30 Sep 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	91,195	$366,000	—	30 Sep 2022	13F
Invesco Ltd.	13F	Company	0.03%	74,828	$300,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.03%	72,200	$290,000	—	30 Sep 2022	13F
Vident Investment Advisory, LLC	13F	Company	0.03%	73,858	$287,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0.03%	69,169	$278,000	—	30 Sep 2022	13F
Squarepoint Ops LLC	13F	Company	0.03%	66,434	$266,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	48,437	$194,000	—	30 Sep 2022	13F
ALPS ADVISORS INC	13F	Company	0.02%	45,137	$181,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	43,967	$176,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	34,160	$137,000	—	30 Sep 2022	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.01%	32,756	$131,352	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	29,910	$119,000	—	30 Sep 2022	13F
Diametric Capital, LP	13F	Company	0.01%	29,022	$116,000	—	30 Sep 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.01%	27,399	$110,000	—	30 Sep 2022	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.01%	24,522	$98,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.01%	22,261	$89,000	—	30 Sep 2022	13F
CREDIT SUISSE AG/	13F	Company	0.01%	21,565	$86,000	—	30 Sep 2022	13F

Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2022

As of 31 Dec 2022, NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,863,205 shares. The largest 10 holders included HHLR ADVISORS, LTD., Cederberg Capital Ltd, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, Artal Group S.A., BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, Temasek Holdings (Private) Ltd, and UBS Group AG. This page lists 63 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

-6

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.